Search research articles
Contact Us
Filters
Showing results (11-20 of 68) with videos related to
Page
of 7
Sort By:
Journal of Combinatorial Chemistry
|
March 15, 2005
Liquid-phase synthesis of combinatorial libraries based on 7-trifluoromethyl-substituted pyrazolo[1,5-a]pyrimidine scaffold
Igor L Dalinger, Irina A Vatsadse, Svyatoslav A Shevelev, et al.
Current Alzheimer Research
|
November 11, 2016
AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models
Alexandre V Ivachtchenko, Yan A Ivanenkov, Mark S Veselov, et al.
International Journal of Molecular Sciences
|
July 14, 2023
Aprotinin-Drug against Respiratory Diseases
Alexandre V Ivachtchenko, Andrey A Ivashchenko, Dmitrii O Shkil, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
March 14, 2007
Recent progress in discovery and development of antimitotic agents
Alex Kiselyov, Konstantin V Balakin, Sergey E Tkachenko, et al.
Mini Reviews in Medicinal Chemistry
|
October 16, 2008
CXCR4 receptor as a promising target for oncolytic drugs
Yan Lavrovsky, Yan A Ivanenkov, Konstantin V Balakin, et al.
European Journal of Medicinal Chemistry
|
November 27, 2009
8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists
Alexandre V Ivachtchenko, Oleg D Mitkin, Sergey E Tkachenko, et al.
Journal of Combinatorial Chemistry
|
January 9, 2007
Synthesis of heterocyclic compounds possessing the 4H-thieno[3,2-b]pyrrole moiety
Alexey P Ilyin, Irina G Dmitrieva, Veronika A Kustova, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 27, 2005
Synthesis and antimicrobial activity of 5-hydroxymethyl- 8-methyl-2-(N-arylimino)-pyrano[2,3-c]pyridine-3-(N-aryl)-carboxamides
Irina O Zhuravel', Sergiy M Kovalenko, Alexandre V Ivachtchenko, et al.
Current Cancer Drug Targets
|
January 29, 2008
Novel mitotic targets and their small-molecule inhibitors
Alexandre V Ivachtchenko, Alex S Kiselyov, Sergey E Tkachenko, et al.
Current Cancer Drug Targets
|
June 10, 2008
Regulators of chemokine receptor activity as promising anticancer therapeutics
Konstantin V Balakin, Yan A Ivanenkov, Sergey E Tkachenko, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 68) with videos related to
Sort By:
Page
of 7
Journal of Combinatorial Chemistry
|
March 15, 2005
Liquid-phase synthesis of combinatorial libraries based on 7-trifluoromethyl-substituted pyrazolo[1,5-a]pyrimidine scaffold
Igor L Dalinger, Irina A Vatsadse, Svyatoslav A Shevelev, et al.
Current Alzheimer Research
|
November 11, 2016
AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models
Alexandre V Ivachtchenko, Yan A Ivanenkov, Mark S Veselov, et al.
International Journal of Molecular Sciences
|
July 14, 2023
Aprotinin-Drug against Respiratory Diseases
Alexandre V Ivachtchenko, Andrey A Ivashchenko, Dmitrii O Shkil, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
March 14, 2007
Recent progress in discovery and development of antimitotic agents
Alex Kiselyov, Konstantin V Balakin, Sergey E Tkachenko, et al.
Mini Reviews in Medicinal Chemistry
|
October 16, 2008
CXCR4 receptor as a promising target for oncolytic drugs
Yan Lavrovsky, Yan A Ivanenkov, Konstantin V Balakin, et al.
European Journal of Medicinal Chemistry
|
November 27, 2009
8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists
Alexandre V Ivachtchenko, Oleg D Mitkin, Sergey E Tkachenko, et al.
Journal of Combinatorial Chemistry
|
January 9, 2007
Synthesis of heterocyclic compounds possessing the 4H-thieno[3,2-b]pyrrole moiety
Alexey P Ilyin, Irina G Dmitrieva, Veronika A Kustova, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 27, 2005
Synthesis and antimicrobial activity of 5-hydroxymethyl- 8-methyl-2-(N-arylimino)-pyrano[2,3-c]pyridine-3-(N-aryl)-carboxamides
Irina O Zhuravel', Sergiy M Kovalenko, Alexandre V Ivachtchenko, et al.
Current Cancer Drug Targets
|
January 29, 2008
Novel mitotic targets and their small-molecule inhibitors
Alexandre V Ivachtchenko, Alex S Kiselyov, Sergey E Tkachenko, et al.
Current Cancer Drug Targets
|
June 10, 2008
Regulators of chemokine receptor activity as promising anticancer therapeutics
Konstantin V Balakin, Yan A Ivanenkov, Sergey E Tkachenko, et al.
Page
of 7